Bain Capital Life Sciences Investors, LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,002,865
-61.4%
8,663,6730.0%1.23%
-58.1%
Q2 2023$28,503,484
+79948.0%
8,663,6730.0%2.94%
-34.0%
Q1 2023$35,608
-29.9%
8,663,6730.0%4.45%
-21.6%
Q4 2022$50,769
-99.9%
8,663,6730.0%5.67%
-18.9%
Q3 2022$58,566,000
+46.3%
8,663,6730.0%6.99%
+48.9%
Q2 2022$40,026,000
+53.8%
8,663,673
+32.8%
4.69%
+85.8%
Q1 2022$26,023,000
-22.3%
6,522,030
+21.1%
2.53%
-4.9%
Q4 2021$33,499,000
-3.9%
5,385,667
+45.7%
2.66%
+22.9%
Q3 2021$34,850,000
-30.6%
3,695,6670.0%2.16%
-34.2%
Q2 2021$50,187,000
-16.1%
3,695,6670.0%3.29%
-2.9%
Q1 2021$59,796,000
-34.8%
3,695,667
+7.3%
3.39%
-41.2%
Q4 2020$91,689,000
+42.9%
3,445,6670.0%5.76%
-3.7%
Q3 2020$64,158,000
-20.4%
3,445,6670.0%5.98%
-29.2%
Q2 2020$80,629,0003,445,6678.44%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 796,458$14,830,00012.35%
Consonance Capital Management LP 3,468,171$64,577,0007.87%
Sarissa Capital Management LP 2,837,000$52,824,0006.22%
Bain Capital Life Sciences Investors, LLC 3,445,667$64,158,0005.98%
Ghost Tree Capital, LLC 1,050,000$19,551,0005.65%
NEA Management Company, LLC 5,959,520$110,966,0004.70%
Soleus Capital Management, L.P. 393,041$7,318,0003.88%
ACUTA CAPITAL PARTNERS, LLC 667,500$12,429,0003.38%
Avoro Capital Advisors LLC 6,800,000$126,616,0001.80%
FNY Investment Advisers, LLC 199,800$3,720,0001.57%
View complete list of MERSANA THERAPEUTICS INC shareholders